STILNOX CR 6.25MG MODIFIED RELEASE TABLET

Product Information

Registration Status: Active

STILNOX CR 6.25MG MODIFIED RELEASE TABLET is approved to be sold in Singapore with effective from 2008-01-28. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN13402P.

This product contains Zolpidem Tartrate 3mg & 3.250mg in the form of TABLET, MULTILAYER, EXTENDED-RELEASE. It is approved for ORAL use.

This product is manufactured by SANOFI WINTHROP INDUSTRIE in FRANCE.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Zolpidem Tartrate


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank